In the wake of the COVID-19 pandemic, the world was confronted with a stark reality: access to essential health technologies—vaccines, therapeutics, and diagnostics—remains deeply unequal. The Global Coalition for Local and Regional Production, Innovation, and Equitable Access is launched today in Rio de Janeiro with the support of the Governments of Brazil, Germany, Indonesia, France, South Africa, Turkey, UK and the AU and EU and including both NGO’s and the private sector as a bold and necessary response to this challenge, representing a transformative shift toward a more resilient, inclusive, and equitable global health system.
A Coalition Born from Urgency and Vision
The coalition was established through a shared recognition that global health inequities are not merely the result of resource scarcity, but of structural imbalances in production, innovation, and access. As highlighted in the presentation, the initiative is “born from the commitment to overcome the health inequities exposed by the COVID-19 pandemic,” advancing a distributed model of innovation and production for essential health technologies.
This vision reflects a paradigm shift: from centralized, limited manufacturing hubs to a diversified global network of local and regional production capacities.
Addressing Deep Structural Inequalities
The Coalition responds to several critical global challenges:
• Manufacturing capacity remains concentrated in a handful of countries
• Low- and middle-income countries (LMICs) face persistent barriers to accessing essential health products
• Neglected diseases continue to affect over a billion people worldwide
• Technological and productive asymmetries hinder timely and sovereign responses to health crises
These inequities are not only unjust—they pose a direct threat to global health security. Without distributed manufacturing, entire regions remain vulnerable to delayed or insufficient access to life-saving tools.
A Model Built on Cooperation and Solidarity
At its core, the Coalition is grounded in voluntary cooperation among G20 and non-G20 countries, international organizations, and a wide range of partners. Its framework emphasizes:
• Coordination with existing global initiatives
• Focus on vaccines, therapeutics, diagnostics, and other essential technologies
• Prioritization of vulnerable populations and neglected diseases
• Strengthening local and regional production as a strategy for resilience
This collaborative model recognizes that no single country or institution can address global health inequities alone. Instead, it calls for shared responsibility and collective action.
From Vision to Action: Building Capacity and Resilience
The Coalition is not merely aspirational—it is operational. Its principles include:
• Expanding innovation networks and workforce training
• Supporting voluntary technology transfer and regulatory cooperation
• Strengthening quality infrastructure and regulatory systems
• Implementing pilot projects, such as dengue-focused initiatives, using a “learning-by-doing” approach
These operational pillars ensure that the Coalition delivers tangible, measurable outcomes that build long-term capacity rather than short-term fixes.
Benefits for a More Balanced Global Health System
Participation in the Coalition offers wide-ranging benefits:
• Enhanced access to essential health products
• Increased regional autonomy and resilience
• Integration into global R&D and innovation ecosystems
• Strengthened regulatory and technological capabilities
• Economic and industrial development opportunities
These outcomes are not only beneficial for participating countries—they contribute to a more stable and secure global health architecture.
Leadership and Global Commitment
With strong institutional leadership—highlighted by Brazil’s role —the Coalition is anchored in credibility, expertise, and global commitment. Its governance structure ensures strategic direction, scientific guidance, and operational coordination, enabling effective implementation across diverse regions.
A Call for Collective Action
Ultimately, the Global Coalition represents more than a policy initiative—it is a moral and strategic imperative. It calls on nations, institutions, and partners to invest not only in their own health systems, but in a shared global future where access to life-saving technologies is not determined by geography or income.
As the Brazilian Health Minister said recently in Frankfurt –
“Together, we can contribute to stronger, more equitable global health capacities.”
Conclusion
In an interconnected world, health equity is not optional—it is essential. The Global Coalition offers a practical, collaborative, and forward-looking pathway to achieve it and I am pleased to personally endorse it. By strengthening local production, fostering innovation, and ensuring equitable access, it lays the foundation for a more just and resilient global health system—one that leaves no one behind.
Read the LinkedIn post here.